Skip to main content

Animations

MJFF Publications

1621 - 1630 of 6420 Results
Title
Year
  • Year
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2024
  • 2025
  • 2022
  • 2022
  • Summary Details
    OPEN
    Title: α-Synuclein aggregates inhibit ESCRT-III through sequestration and collateral degradation
    Journal Name: Molecular Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.molcel.2025.08.022
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Associations between epilepsy-related polygenic risk and brain morphology in childhood
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awaf259
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Lifespan Tree of Brain Anatomy: Diagnostic Values for Motor and Cognitive Neurodegenerative Diseases
    Journal Name: Human Brain Mapping
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/hbm.70336
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Applications of machine learning for computer-aided diagnosis of Parkinson’s disease: progress and benchmark case study
    Journal Name: Artificial Intelligence Review
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s10462-025-11347-y
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Predicting Cognitive Decline in Parkinson’s Disease Using Artificial Neural Networks: An Explainable AI Approach
    Journal Name: Brain Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/brainsci15080782
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Chronic hyperactivation of midbrain dopamine neurons causes preferential dopamine neuron degeneration
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.98775.3
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Long‐Read Sequencing Unravels the Complexity of Structural Variants in PRKN in Two Individuals with Early‐Onset Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29914
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Lrrk2 G2019S mutation incites increased cell-intrinsic neutrophil effector functions and intestinal inflammation in a model of infectious colitis
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-01077-x
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Opicapone in Uk Clinical Practice: effectiveness, Safety and Cost Analysis in Patients With Parkinson’s Disease
    Journal Name: Neurodegenerative Disease Management
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.2217/nmt-2021-0057
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Targeted Metabolomic Analysis in Alzheimer’s Disease Plasma and Brain Tissue in Non-Hispanic Whites
    Journal Name: Journal of Alzheimer's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jad-215448
    Citation Count: 39
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.